FDA Inspection 788585 — Laclede, Inc.

Laclede, Inc. — FEI 2022474

The FDA completed an inspection of Laclede, Inc. on June 27, 2012 in Rancho Dominguez, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 27, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rancho Dominguez, CA (United States)

Citations

IDCFRDescription
176821 CFR 211.137(b)Storage conditions
182321 CFR 211.84(c)(4)Top/Middle/Bottom container sampling
188321 CFR 211.165(a)Testing and release for distribution
360321 CFR 211.160(b)Scientifically sound laboratory controls
431421 CFR 211.84(d)(2)Reports of Analysis (Components)